| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.2 |